Biomarkers Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Biomarkers Market Size During the Forecast Period?
The dimensions of the biomarkers market have witnessed a swift acceleration in the past years. An exponential growth can be expected as projections indicate a surge from $68.77 billion in 2024 to a whooping $78.14 billion by 2025, reflecting a compound annual growth rate (CAGR) of 13.6%. The considerable growth experienced during the preceding period is credited to improvements in genomics and proteomics technologies, heightened occurrences of chronic diseases, an increasing focus on specialized medicine, a rising need for tandem diagnostics, and widening applications in pharmaceutical development.

Over the coming years, the biomarkers market size is projected to experience a swift increase. Its value is predicted to escalate to $135.14 billion in 2029, with a compound annual growth rate (CAGR) of 14.7%. Several factors are believed to contribute to this growth during the forecast period, namely, the heightened focus on early disease detection and prevention, the expansion of biomarkers in fields such as oncology and immunotherapy, the increase in investment towards precision medicine initiatives, the rise of liquid biopsy as a non-invasive method for biomarker detection, and the growing preference for biomarkers in drug discovery and development. The expected trends throughout this period include the creation of multi-biomarker panels, the emergence of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data into biomarker research, and the exploration of microbiome-based biomarkers.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

What Are the High-Growth Segments in the Biomarkers Market?
The biomarkers market covered in this report is segmented -

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Key Drivers Are Expected to Influence Future Biomarkers Market Growth?
The escalation in heart-related illnesses is predicted to spur the expansion of the biomarkers market during the anticipated period. The application of biomarkers in heart disease patients has shown a significant surge in recent years. Presently, natriuretic peptides are the most frequently used biomarker offering assistance in diagnosing heart failure patients. Biomarkers such as high sensitivity C-reactive protein (circulating biomarkers) are leveraged for diagnosing heart failure. Heart disease stands as a primary cause of death for people across most racial and ethnic groups in the United States. The surge in heart-related conditions will thus fuel the need for biomarkers. For example, as per a report issued by the American College of Cardiology, a US-based non-profit medical association, in August 2022, it is predicted that all four cardiovascular risk factors will see a rise between 2025 and 2060 within the United States. Diabetes is expected to see the highest surge at 39.3% impacting 55 million individuals, closely followed by dyslipidemia (27.6% affecting 126 million), hypertension (25.1% affecting 162 million), and obesity (18.3% affecting 126 million). The study further noticed the most substantial projected increases in cardiovascular disease rates for stroke (33.8% affecting 15 million) and heart failure (33.4% affecting 13 million), succeeded by ischemic heart disease (30. 7% affecting 29 million) and heart attack (16.9% affecting 16 million). Owing to the upswing in heart-related illnesses and related deaths, growth in the biomarkers sector will be boosted.

Which Companies Hold the Largest Share Across Different Biomarkers Market Segments?
Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

What Trends Are Driving Growth in The Biomarkers Market?
Leading firms in the biomarker industry are concentrating on creating innovative solutions such as cutting-edge biological indicators to drive development by incorporating collaborative research, technological integration, and strong clinical validation. A fresh biological marker can be a molecular, genetic or cellular characteristic that plays a role in detecting or tracking diseases, with potential impacts for individualized medicine. For instance, in September 2024, Genialis, an American company focusing on computational precision medicine, introduced an industry-first biomarker. This groundbreaking biomarker boosts the predictive precision for patient responses to KRAS inhibitors, which facilitates the formulation of customised treatment plans and improves patient results. Its wide-range usage in various cancer types aids in streamlining drug development and refining the selection of patients for aimed treatments.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Are the Emerging Geographies for The Biomarkers Market Growth?
North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Biomarkers Market?
2. What is the CAGR expected in the Biomarkers Market?
3. What Are the Key Innovations Transforming the Biomarkers Industry?
4. Which Region Is Leading the Biomarkers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.